CAS NO: | 1196800-39-1 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | Omadacycline (PTK 0796) hydrochloride, a first-in-class orally active aminomethylcyclineantibacterial, is a member of thetetracyclineclass ofantibiotics. Omadacycline hydrochloride acts through the inhibition ofbacterialprotein synthesisby binding to the 30S ribosomal subunit. Omadacycline hydrochloride possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline hydrochloride can be used for the research of acutebacterialskin and skin-structure infections, community-acquired pneumonia, and urinary tract infections[1][2][3][4]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | Omadacycline displays activity against methicillin-resistantStaphylococcus aureus(MRSA), vancomycin-resistantEnterococcus(VRE), beta-hemolytic streptococci, penicillin-resistantStreptococcus pneumonia(PRSP) andHaemophilus influenzae (H. influenzae), with MIC90s of 1.0, 0.25, 0.5, 0.25 and 2.0 μg/mL respectively[2]. | ||||||||||||||||
体内研究 (In Vivo) | Omadacycline (0.11-18 mg/kg; a single i.v.) exhibits efficacy againstStreptococcus pneumonia,Escherichia coli, andStaphylococcus aureusin mice systemic infection model, with ED50s ranging from 0.30 mg/kg to 3.39 mg/kg[2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 593.11 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C29H40N4O7.HCl | ||||||||||||||||
CAS 号 | 1196800-39-1 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 105 mg/mL(177.03 mM;Need ultrasonic) H2O : ≥ 50 mg/mL(84.30 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |